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The N-end rule and regulation of 
apoptosis
Alexander Varshavsky
The ubiquitin-dependent N-end rule pathway targets proteins for degradation through their destabilizing 
N-terminal residues. This pathway is known to control the import of peptides, chromosome stability and
cardiovascular development. A new report identifies yet another function of the N-end rule pathway: the
regulation of apoptosis through degradation of Drosophila melanogaster DIAP1.
Apoptosis (programmed cell death) ina multicellular organism makes possi-ble the selective elimination of super-
numerary, damaged or otherwise abnormal
cells. In most cases, the apoptotic death of a
cell is caused by the activity of caspases, a
set of sequence-specific intracellular pro-
teases that are normally dormant, but
which can be activated by signals that
induce apoptosis1,2. Elaborate mechanisms
have evolved to activate caspases through
many and varied physiological inputs while
maintaining a robust negative control over
the activation process. The key caspases
must be activated to a significant threshold
level before committing a cell to apoptotic
death. Inhibitors of apoptosis (IAPs) have a
major role in the negative control of cas-
pase activation3. The ubiquitin (Ub) sys-
tem, a large array of proteolytic and non-
proteolytic pathways that involve Ub-pro-
tein conjugation, is also essential for regula-
tion of apoptosis: the major IAP proteins
are specific Ub ligases whose ability to ubiq-
uitylate either themselves or caspases (and
other IAP-bound proteins) is important for
IAP functions3–7.
On page 467 of this issue, Ditzel, Meier
and colleagues report a major new connec-
tion between the Ub system and apoptosis8.
They demonstrate that Drosophila DIAP1,
an inhibitor of apoptosis, is cleaved at posi-
tion 20 by activated caspases, yielding a
slightly shorter version of DIAP1 that is
degraded by the Ub-dependent N-end rule
pathway. This degradation, which does not
involve the Ub ligase activity of DIAP1, is
shown by the authors to be important for
the function of DIAP1 as an inhibitor of
apoptosis8.
The N-end rule relates the in vivo half-
life of a protein to the identity of its N-ter-
minal residue9–12; the underlying prote-
olytic pathway is called the N-end rule
pathway (Fig. 1). Its Ub ligases target pro-
tein substrates that bear specific (destabi-
lizing) N-terminal residues. The corre-
sponding degradation signal (degron),
called the N-degron, consists of a sub-
strate’s destabilizing N-terminal residue
and an internal Lys residue, the latter being
the site of formation of a substrate-linked
poly-Ub chain. A ubiquitylated substrate is
processively degraded by the 26S protea-
some10. Because an N-degron must be pro-
duced through a proteolytic cleavage that
yields a destabilizing N-terminal residue, a
nascent N-end rule substrate contains a
cryptic N-degron, called a pro-N-degron.
In the yeast Saccharomyces cerevisiae,
where a mechanistic understanding of the
pathway is most detailed, the Ub ligase
UBR1 recognizes (binds to) the primary
destabilizing N-terminal residues Arg, Lys,
His, Phe, Trp, Leu, Tyr and Ile (Fig. 1)10,13.
Several other N-terminal residues function
as tertiary (Asn and Gln) and secondary
(Asp and Glu) destabilizing residues in that
they are recognized by UBR1 after their
enzymatic conjugation to Arg, a primary
destabilizing residue. With N-terminal Asn
and Gln, their conjugation to Arg is preced-
ed by their enzymatic deamidation14. In
metazoans, but not in fungi such as S. cere-
visiae, N-terminal Cys is yet another terti-
ary destabilizing residue, in that the arginy-
lation of Cys is preceded by its (apparently)
enzymatic oxidation12 (Fig. 1).
One function of the N-end rule pathway
is regulation of peptide import. The UBR1
Ub ligase of the S. cerevisiae N-end rule
pathway contains a distinct (third) sub-
strate-binding site13 that recognizes an
internal (non-N-terminal) degron in the
pathway’s substrates, such as the transcrip-
tional repressor CUP9. Dipeptides with
destabilizing N-terminal residues bind to
UBR1, thereby increasing the ability of
UBR1 to target CUP9 for degradation11.
The resulting decrease in CUP9 concentra-
tion causes derepression of the PTR2 gene,
which encodes a peptide transporter.
Through this positive feedback in the
UBR1–CUP9–PTR2 circuit, cells can sense
the presence of extracellular peptides and
react by accelerating their uptake11.
Another function of the N-end rule
pathway is the maintenance of chromo-
some stability. SCC1, a subunit of the S.
cerevisiae cohesin complex, is cleaved by the
ESP1 separase at the metaphase–anaphase
transition, yielding a C-terminal fragment
of SCC1 that bears N-terminal Arg and is
degraded by the N-end rule pathway15. In
ubr1∆ cells, failure to degrade the SCC1
fragment results in chromosome
instability15. In mammalian cells, a fraction
of the orthologous SCC1 (RAD21) cohesin
subunit is also cleaved by separase at the
metaphase–anaphase transition16, and the
resulting C-terminal fragment of SCC1,
similarly to its yeast counterpart, is a
short-lived substrate of the mammalian N-
end rule pathway (J. Zhou, Y. T. Kwon and
A.V., unpublished observations). The N-
end rule pathway is also required for car-
diovascular development in mammals12.
We now learn about yet another func-
tion of this pathway: the regulation of
apoptosis. Although caspases have been
known to produce protein fragments bear-
ing destabilizing N-terminal residues10, the
work by Ditzel et al.8 demonstrates for the
first time that at least one such fragment —
of Drosophila DIAP1 — is, in fact, a physio-
logical N-end rule substrate and that degra-
dation of the fragment by the N-end rule
pathway is important for regulation of
apoptosis. Drosophila DIAP1 is the key
inhibitor of apoptosis in Drosophila: a dele-
tion of its gene results in apoptotic death of
most cells in early Drosophila embryos3.
Caspase inhibition is the major function of
DIAP1 and other IAP proteins in all multi-
cellular organisms, from animals to plants.
A typical IAP protein is a complicated
device: in addition to its ability to bind, and
thereby to inactivate, specific caspases, it
also contains a RING domain and can
therefore function as a Ub ligase, mediating
either self-ubiquitylation or ubiquitylation
of IAP-bound proteins3.
Reaper, Grim and Hid in Drosophila,
and Smac/DIABLO in mammalian cells
function as activators of apoptosis. These
proteins counteract the protective effects of
IAPs by competing with caspases for binding
to IAPs, thus increasing the levels of active
caspases. Activators of apoptosis can also
increase the rate of self-ubiquitylation (and
subsequent degradation) of IAP proteins. In
addition, at least some of these activators
can inhibit cellular protein synthesis. This
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preferentially decreases the concentrations
of IAP proteins, whose in vivo half-lives
tend to be shorter than the half-lives of
active caspases3. The IAPs fight back, in part
through their ability to be destroyed by the
Ub system together with IAP-bound activa-
tors of apoptosis7. In a non-apoptotic cell,
the IAPs keep an upper hand by being in
stoichiometric excess over the activators of
apoptosis and by physically sequestering
the (relatively few) molecules of activated
caspases, which are produced at significant
rates even in the absence of pro-apoptotic
signals.
The results by Ditzel et al.8 have now
added the N-end rule pathway to this com-
plex picture. It was found that activated cas-
pases cleave the 438-residue DIAP1 protein
at position 20, resulting in an almost full-
length DIAP1 bearing N-terminal Asn, a
tertiary destabilizing residue (Fig. 1). The
Asn-bearing DIAP1 fragment is degraded
by the N-end rule pathway in a manner that
does not require the Ub-ligase activity of
DIAP1 itself8. One would expect
a short-lived protein bearing N-terminal
Asn to be targeted for degradation by the
deamidation–arginylation branch of the 
N-end rule pathway (Fig. 1). Indeed, by
using RNA interference to reduce the
expression of the Drosophila ATE1-encoded
R-transferase (Fig. 1), Ditzel et al.8 demon-
strated that degradation of the Asn-bearing
DIAP1 fragment required arginylation.
Remarkably, the caspase-mediated cleavage
at position 20 that converts DIAP1 into an
N-end rule substrate was found to be essen-
tial for the ability of DIAP1 to suppress the
pro-apoptotic activity of Reaper8. In exper-
iments with whole flies and cells in culture,
Ditzel et al.8 went on to show that degrada-
tion of the DIAP1 fragment by the N-end
rule pathway was a major cause of the anti-
Reaper activity of DIAP1 .
Thus, paradoxically, although the N-end
rule-mediated degradation of DIAP1
decreases the level of this key apoptotic
inhibitor and would therefore be expected to
lower the apoptotic threshold, this degrada-
tion is important for DIAP1-mediated inhi-
bition of apoptosis. A parsimonious inter-
pretation of these findings8, in conjunction
with earlier evidence, is that the anti-apop-
totic activity of DIAP1 is mediated by Ub-
dependent codegradation of both DIAP1
and its associated pro-apoptotic ligands,
such as caspases and Reaper. This codegrada-
tion could be achieved either through the 
N-end rule pathway or through the Ub-ligase
activity of DIAP1 itself. Exactly how these
alternative targeting routes are chosen for
individual DIAP1 molecules and the exact
stoichiometries of codegraded DIAP1-bound
ligands remains to be determined. At least one
mammalian counterpart of Drosophila
DIAP1, called XIAP, is also cleaved by activat-
ed caspases17. The resulting C-terminal frag-
ment of XIAP bears N-terminal Ala, a type-3
primary destabilizing residue in the mam-
malian N-end rule (Fig. 1; the type-3 branch
of the N-end rule pathway is the least
explored one; its Ub ligase remains to be
characterized).
Fig. 2 provides a partial list of fly and
mammalian proteins that are known to be
cleaved by caspases to yield C-terminal
fragments with destabilizing N-terminal
residues. Thus far, the Asn-bearing C-ter-
minal fragment of Drosophila DIAP1 is the
only member of this list that has actually
been shown to be a physiological N-end
rule substrate8. The set of proteins whose
cleavage by caspases produce putative 
N-end rule substrates encompasses a broad
Figure 1 The N-end rule pathway in mammals. N-terminal residues
are indicated by single-letter abbreviations. Ovals denote the rest
of a protein substrate. The Asn-specific N-terminal amidase
NTAN1 converts N-terminal Asn into Asp14. N-terminal Gln is de-
amidated by another (unidentified) amidase. N-terminal Asp, Glu
and Cys are conjugated to Arg by Arg-tRNA protein transferases
(R transferases), encoded by the ATE1 gene12. N-terminal Cys is
arginylated after its (apparently) enzymatic oxidation to either
sulphinic or cysteic acid residue (denoted as C*)12. In the yeast
S. cerevisiae, the primary destabilizing N-terminal residues Arg,
Lys, His (type-1 residues), and Phe, Leu, Trp, Tyr and Ile (type-2
residues) are recognized by the type-1 and type-2 substrate-bind-
ing sites of UBR1 in a complex with the RAD6 ubiquitin-conjugat-
ing enzyme (E2)10,13. In mammals, the same residues are recog-
nized by either UBR1 or UBR2 (in complexes with their cognate
E2 enzymes), and also by another, unidentified E3 (ref. 22). In
mammals, but not in yeast, Ala, Ser and Thr are primary (type-3)
destabilizing residues recognized by an uncharacterized Ub lig-
ase. Both S. cerevisiae UBR1 and its mammalian counterparts
contain yet another (third) substrate-binding site that targets pro-
teins through their internal (non-N-terminal) degrons11,13.
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range: phosphokinases, Ub ligases, tran-
scription factors, DNA topoisomerases and
regulators of the cell cycle (Fig. 2). This set
includes both inducers and inhibitors of
apoptosis; it also contains proteins, such as
lamin and vimentin, that are normally
cleaved by caspases at later (committed)
stages of apoptosis. Caspases also have
apoptosis-independent functions18. In
addition, the suppression of caspase activa-
tion in vivo is not tight enough to preclude
caspase activation entirely. Therefore even a
normal, unstressed cell invariably contains
significant levels of caspase-produced pro-
tein fragments, including the fragments
described in Fig. 2. If a caspase-produced
C-terminal fragment of a given protein has
a pro-apoptotic activity or is otherwise
toxic (such examples are known), one way
to reduce accumulation of this fragment
would be to make it short-lived. This teleol-
ogy, which is additional to and distinct
from the DIAP1-type function of the
N-end rule pathway8, may be a major
source of evolutionary pressure that result-
ed in the frequent presence of destabilizing
residues at the amino termini of protein
fragments produced by caspases.
The phenotypes that result from the
absence of the deamidation–arginylation
branch of the N-end rule pathway vary
greatly in their severity amongst different
organisms. For example, arginylation-defi-
cient ate1∆ S. cerevisiae cells are otherwise
seemingly normal19. The arginylation- defi-
cient ATE1−/− mutant of the plant
Arabidopsis thaliana is viable but exhibits
delayed leaf senescence20. Furthermore,
arginylation-deficient ATE1−/− mice die as
embryos, at least partly from cardiovascular
defects12. In contrast, NTAN1−/− mice, which
lack the Asn-specific N-terminal amidase
but retain the arginylation step of the N-
end rule pathway, exhibit abnormal behav-
iours but otherwise seem to be wild type14.
Although the null ate1 phenotype of
D. melanogaster remains to be determined,
it will probably be severe, because even het-
erozygous ATE1+/− flies in a genetic back-
ground that ectopically expresses Reaper in
the developing retina fail to eclose and die
in their pupae cases8.
Processing proteases that convert
pro-N-degrons into N-degrons have long
been envisioned as regulated entry points to
the N-end rule pathway9,10. Such proteases
include both methionine aminopeptidases
(Met-APs)21 and cohesin-cleaving separas-
es15. The study by Ditzel et al.8 has now
demonstrated that caspases, too, can func-
tion as specific entry points to the N-end
rule pathway and that degradation of a cas-
pase-produced N-end rule substrate such as
DIAP1 by this pathway is important for the
control of apoptosis. Given this insight and
the broad range of caspase-produced pro-
tein fragments that are putative N-end rule
substrates (Fig. 2), it would be particularly
informative to identify among such frag-
ments those that are actually destroyed by
the N-end rule pathway and to determine
the functions of this degradation. The set of
proteases that produce physiological N-end
rule substrates is unlikely to be confined to
Dm-DIAP1
Hs-PKCδ
Hs-DNAPKcs
Mm-Lamin  A
Hs-Caspase-1 (ICE)
Mm-CDC42
Hs-MDM2
Hs-Cyclin  E1
Hs-ETK / BMX
Hs-Vimentin
Hs-p21
Hs-Huntingtin
Hs-Topoisomerase  I
Hs-HEF1
Hs-APAF1
Hs-HPK1
43816
...FDQVD NNTN....S
665226
1,19415
675238
4,1282709
491357
676325
834626
833381
191117
3,144509
1,194142
46681
164108
410286
404115
...EDMQD NSGT....D
...GDEVD NKVK....M 
...LVEID NNGK....M 
...QAVQD NPAM....H 
...IDLRD DPST....F
...FDVPD CKKT....P 
...VLDVD CWQV....H
...EDFPD WWQV....H
...QDSVD FSLA....E
...EDHVD LSLS....P
...ADSVD L ASC....C
...EDDAD YKPK....F
...MDDYD Y KTS....E 
...ALEKD IKTS....E
...YDDVD IPTP....L
Figure 2 Confirmed and putative N-end rule substrates produced by caspases. Amino-
acid residues are indicated by single-letter abbreviations. The caspase-recognition
motifs (green) precede an arrowhead indicating the site of cleavage and a destabilizing
residue (red) that becomes N-terminal in a caspase-produced fragment. The numbers
represent a residue preceding a caspase recognition motif and the last encoded
residue of the protein, respectively. The prefixes Dm, Hs and Mm refer to proteins of
Drosophila melanogaster, Homo sapiens and Mus musculus, respectively. All fragments
in this list were actually observed (the corresponding papers will be cited in a more
detailed review elsewhere). Thus far, the degradation by the N-end rule pathway and
the physiological relevance of this degradation have only been demonstrated for
Drosophila DIAP1 (ref. 8).
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Met-APs, caspases and separases. For exam-
ple, the cleavage specificity of calcium-acti-
vated proteases called calpains and the
properties of other, less well characterized
cytosolic and/or nuclear proteases suggest
that they, too, may function as upstream
components of the N-end rule pathway.
The DIAP1 findings by Ditzel et al.8 are
exciting not only because of what they tell
us about the link between apoptosis and the
N-end rule pathway. They also suggest the
existence of other caspase-produced N-end
rule substrates, of which the list in Fig. 2 is
just the start. These substrates remain to be
identified and understood in the context of
N-end rule’s physiology.
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Despite its eventual complexity, the developing nervous system
seems to be directed by an elegant economy of cues. We are
beginning to learn that factors can perform more than one job
during its development, and in the April issue of Cell (113, 11–23
(2003)), Tessier-Lavigne and colleagues provide compelling evi-
dence that Sonic Hedgehog (Shh), a morphogen known for its
role in neural tissue patterning, also functions later to attract
navigating axons.
During development of the nervous system, axons are guided
by a combination of attractive and repulsive cues. In the embry-
onic spinal cord, a subset of axons are attracted from the dorsal
neural tube towards the floor plate, where they form axon com-
missures. It is well established that outgrowth of these axons and
their subsequent attraction towards the floor plate is directed by
the long-range chemoattractant Netrin-1. However, the defects
observed in Netrin-1 mutants have hinted that residual chemoat-
tractant activity may reside in the floor plate in its absence and
raise the possibility that a second attractant is guiding the axons.
Tessier-Lavigne and colleagues now show that this second signal
is provided by Shh. Interestingly, unlike Netrin-1, Shh cannot
function as a permissive factor to stimulate the outgrowth of
these axons per se, but seems to be important both in vitro and in
vivo for their subsequent routing.
The authors find that both COS cells and tissue explants
expressing Shh, similarly to those expressing Netrin-1, can reori-
entate commissural axons. The chemoattractant effects of Shh
seem to require Smoothened (Smo; see figure), a transmem-
brane protein known to function downstream of Shh in other
contexts. To exclude the possibility that Shh might affect guid-
ance indirectly, they also confirmed that it cannot induce repat-
terning of older spinal cord tissue in which the axons grow, as it
can earlier in development. Moreover, they showed that applying
a soluble source of Shh close to growing axons in culture was suf-
ficient to trigger axon turning, an effect that also required Smo
activity.
Finally, they asked whether Shh signalling is required in
vivo. Using the Cre-LoxP recombinase system, they selectively
disrupted Smo function in subsets of dorsal spinal cord cells,
including commissural neurons, and showed that this results in
defects in axon guidance. Importantly, this suggests that the Shh
signal is required autonomously in the commissural neurons
themselves.
Together, these findings show that in addition to its earlier
role in directing ventral tissue patterning, Shh functions later
as a chemoattractant, guiding axons towards the floor plate.
This adds to a rapidly growing list of factors that are re-used
by the embryo for diverse functions during development. We
know that another family of morphogens, the bone morpho-
genetic proteins (BMPs), which pattern the dorsal spinal cord,
function later to repel commissural axons away from the dor-
sal midline. So a model begins to emerge where Shh and
BMPs, which initially cooperate during patterning along the
dorsoventral axis, pair up again to lend commissural axons a
guiding hand.
ALISON SCHULDT
Morphogens recycled
fp fp
Smo activity in the floor plate. Netrin-1-mutant floor plate
attracts commissural axons, revealing a second chemoattrac-
tant from the floor plate (left). Cyclopamine, an inhibitor of
Smo, inhibits the Netrin-independent activity of the floor plate,
indicating that Shh signalling is required for this activity (right).
fp, floor plate. Reprinted from Charron et al. 113, 11–23 
(2003) with permission from Elsevier.
© 2003 Nature Publishing Group
